Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

AMD vs AMS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMD Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

AMD Overall Winner 6-Pillar Tally: AMD 6 – 0 AMS Matrix Metrics: AMD 8 – 2 AMS

As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over American Shared Hospital Services (AMS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMD carries a Unified Composite Score of 48.7/100 (HOLD) at $504.28 (28.5x Forward P/E, 17.8% operating margin), whereas AMS carries 33.8/100 (SELL) at $1.07 (44.6x Forward P/E, -7.4% operating margin).

  • Technical & Structure Timing Caution: AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.8); meanwhile AMS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMD vs AMS
AMD NASDAQ Head-to-Head Winner
Advanced Micro Devices
Semiconductors & Related Devices
$504.28
-5.58% 1D
Market Cap $875.9B
TTM Revenue $45.4B
Forward P/E 28.5x
Beta / 30D Vol 3.59β · 118% Vol
Unified Composite Score
48.7 / 100 HOLD
Tech 22.0 Fund 42.0 Flow 68.0 Mom 37.6
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 46.8 · SMA20: $517.33 · SMA50: $555.09
AMS NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap $7.2M
TTM Revenue $30M
Forward P/E 44.6x
Beta / 30D Vol 0.18β · 46% Vol
Unified Composite Score
33.8 / 100 SELL
Tech 24.0 Fund 38.0 Flow 50.0 Mom 30.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.9%), weak momentum, RSI 27
RSI-14: 27.1 · SMA20: $1.21 · SMA50: $1.32

6-Pillar Scorecard Institutional Category Breakdown (AMD 6 – 0 AMS)

Columns: Metric · AMD · AMS
1. Valuation Multiples AMD
Forward P/E 28.5x 44.6x
Trailing P/E 114.1x 44.6x
PEG Ratio 0.48x N/M
EV / Revenue 19.3x 0.8x
2. Growth & Scale AMD
Revenue Growth (YoY) +44.7% +19.2%
Earnings Growth (YoY) +93.8% -38.1%
TTM Revenue (USD) $45.4B $30M
Market Cap $875.9B $7.2M
3. Profitability & Quality AMD
Gross Margin 56.0% 34.8%
Operating Margin 17.8% -7.4%
Net Profit Margin 16.8% -5.8%
Return on Equity (ROE) 12.0% -12.1%
4. Balance Sheet & Cash Flow AMD
Cash Generation (TTM) $7.06B -$916,000
Cash Flow Margin 15.5% -3.0%
Net Cash / Leverage $1.51B Net Debt (0.13x D/E) $17M Net Debt (0.95x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning AMD
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 19.9% (3rd %ile) N/A (N/A)
Put/Call OI Skew 1.07x (Balanced) N/A
OBV Trend / Tech Phase ACCUMULATION · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat AMD
OpEx & R&D Intensity 38.2% of Rev ($17.4B) 42.2% of Rev ($13M)
90D R&D Disclosures 7 papers 0 papers
Competitive Moat Concentrated Oligopoly Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role AI Accelerator & Server Chiplet Designer Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMD (8) vs AMS (2)
Institutional Metric AMD AMS Criterion Row Edge
Market Capitalization
Scale
$875.9B $7.2M Larger Scale AMD
Trailing P/E Ratio
Valuation
114.1x 44.6x Lower Multiple AMS
Forward P/E Ratio
Valuation
28.5x 44.6x Lower Multiple AMD
Revenue Growth (YoY)
Growth
+44.7% +19.2% Higher Growth AMD
Operating Margin (TTM)
Profitability
17.8% -7.4% Higher Margin AMD
Net Profit Margin
Profitability
16.8% -5.8% Higher Margin AMD
Return on Equity (ROE)
Capital Efficiency
12.0% -12.1% Higher ROE AMD
52-Week Range Position
Momentum
67% ($188–$659) 6% ($1–$2) Stronger Trend AMD
Beta / 30D Volatility
Risk Regime
3.59β · 118% Vol 0.18β · 46% Vol Lower Realized Risk AMS
Unified Institutional Score
Composite Signal
48.7 / 100 (HOLD) 33.8 / 100 (SELL) Higher Composite AMD
Trailing 12M Revenue (USD)
Operating Scale
$45.4B $30M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
56.0% 34.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.48x PEG · 19.3x EV/Rev N/M PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$7.06B ($1.51B Net Debt (0.13x D/E)) -$916,000 ($17M Net Debt (0.95x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AMD +11.78 pp
AMD: -4.63% · AMS: -16.41%
3M Horizon AMD +33.25 pp
AMD: +4.11% · AMS: -29.14%
6M Horizon AMD +43.35 pp
AMD: +19.78% · AMS: -23.57%
1Y Horizon AMD +155.6 pp
AMD: +103.37% · AMS: -52.23%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period AMD Revenue AMS Revenue AMD Op. Margin AMS Op. Margin Margin Leader
FY2018 $6.47B $20M 7.0% 9.4% AMS
FY2019 $6.73B $20M 9.4% 7.5% AMD
FY2020 $9.76B $20M 14.0% -53.1% AMD
FY2021 $16.4B $20M 22.2% 7.7% AMD
FY2022 $23.6B $20M 5.4% 12.3% AMS
FY2023 $22.7B $20M 1.8% 1.3% AMD
FY2024 $25.8B $30M 7.4% -9.9% AMD
FY2025 $34.6B $30M 10.7% -12.8% AMD

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMD CONSOLIDATION
103d in phase · OBV ACCUMULATION
Current IV 19.9%
IV Percentile 3rd %ile
Put/Call OI Skew 1.07x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor $500.00
Call Wall Magnet $600.00
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Put Floor: $500.00 (-0.8%) Spot: $504.28 Call Magnet: $600.00 (+19.0%)
  • Extended consolidation (103 days)
  • IV expanding (+13.9%) - uncertainty/bearish
  • Near put wall support ($500)
AMS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AMS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMD Moat Profile Concentrated Oligopoly Moat
AI Accelerator & Server Chiplet Designer
Data center GPU accelerators and server CPU chiplets scale directly with upstream leading-edge foundry utilization and cloud server integration.
OpEx & R&D Reinvestment 38.2% of Rev ($17.4B)
90D Engineering Disclosures 7 Published · LLM Efficiency / Architecture
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries Samsung Electronics ASE Technology Holding
Active 90D Technical Topics:
Edge AI / Inference Chips Hardware-Agnostic ML Compilers Inference Serving / Speculative Decoding KV-Cache / Attention Memory Compression Mixture-of-Experts / Sparse Models
AMS Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $7.2M market capitalization and -7.4% operating margin.
OpEx & R&D Reinvestment 42.2% of Rev ($13M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company GlobalFoundries ASE Technology Holding Amkor Technology

Investor FAQ AMD vs AMS Key Questions & Quantitative Answers

As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over American Shared Hospital Services (AMS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMD carries a Unified Composite Score of 48.7/100 (HOLD) at $504.28 (28.5x Forward P/E, 17.8% operating margin), whereas AMS carries 33.8/100 (SELL) at $1.07 (44.6x Forward P/E, -7.4% operating margin). Technical & Structure Timing Caution: AMD trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.8); meanwhile AMS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AMD leads the Growth & Scale pillar: AMD posts +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin), compared with AMS at +19.2% YoY revenue growth and -38.1% YoY earnings growth on $30M TTM revenue (34.8% gross margin, -7.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), AMD cumulative revenue shifted +435.4% while AMS shifted +50.0%. In operating R&D and SG&A reinvestment, AMD deploys 38.2% of Rev ($17.4B) (7 90-day corporate R&D disclosures) versus 42.2% of Rev ($13M) (0 disclosures) for AMS.

AMD screens cheaper on headline valuation multiples. AMD trades at 28.5x Forward P/E, 114.1x Trailing P/E, 0.48x PEG, and 19.3x EV/Revenue (15.5% FCF margin), whereas AMS trades at 44.6x Forward P/E, 44.6x Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-3.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMD (12.0% ROE) versus AMS (-12.1% ROE) capital efficiency.

In options market volatility and institutional positioning, AMD carries 19.9% implied volatility (3rd %ile, Compressed (<25th %ile)), a 1.07x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.59β · 118% Vol realized risk). By comparison, AMS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.18β · 46% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.